Similar articles

• [d-alpha-Tocopherol in intermittent claudication. Plasma and muscle level in relation to clinical effects].

  Westheim AS, Brox D, Selvaag OA. Westheim AS, et al. Tidsskr Nor Laegeforen. 1977 Mar 20;97(8):390-1. Tidsskr Nor Laegeforen. 1977. PMID: 847701 Norwegian. No abstract available.
• [D-alpha tocopherol in intermittent claudication. A clinical study].

  Westheim AS, Brox D, Selv OA. Westheim AS, et al. Tidsskr Nor Laegeforen. 1975 Jan 10;95(1):13-5. Tidsskr Nor Laegeforen. 1975. PMID: 1089329 Clinical Trial. Norwegian. No abstract available.
• Treatment of intermittent claudication. A reappraisal of the value of alpha-tocopherol.

  BOYD AM, MARKS J. BOYD AM, et al. Angiology. 1963 Apr;14:198-208. doi: 10.1177/000331976301400409. Angiology. 1963. PMID: 14014673 No abstract available.
• [Management of patients with intermittent claudication].

  Fiessinger JN, Sapoval M, Julia P. Fiessinger JN, et al. Rev Prat. 2005 Jun 15;55(11):1190-2, 1195-7. Rev Prat. 2005. PMID: 16164064 Review. French.
• The conundrum of claudication.

  Varcoe RL, Taylor CF, Annett P, Jacobsen EE, McMullin G. Varcoe RL, et al. ANZ J Surg. 2006 Oct;76(10):916-27. doi: 10.1111/j.1445-2197.2006.03904.x. ANZ J Surg. 2006. PMID: 17007623 Review.